Cna Financial Corp Madrigal Pharmaceuticals, Inc. Transaction History

Cna Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 14, 2021	SELL	$108.54 - $125.2 $218,165 - $251,652	-2,010 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$110.06 - $133.7 $135,373 - $164,451	-1,230 Reduced 37.96%	2,010 $223,000
Q3 2020 Nov 12, 2020	BUY	$99.78 - $124.21 $35,920 - $44,715	360 Added 12.5%	3,240 $385,000
Q2 2020 Aug 13, 2020	BUY	$60.13 - $125.71 $173,174 - $362,044	2,880 New	2,880 $326,000

297

22M

819K

640K

Ticker MDGL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 17,103,400
Market Cap $5.34B
Description
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...

Get notified when there are updates to the investment portfolio of Cna Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Cna Financial Corp with notifications on news.